In her address to the membership, Joanne R. Barrick, RPh, Chair, noted that in 2021, implementation of the second year in ISPE’s current Strategic Plan will continue. “While we are changing the ‘how’ we deliver the strategic plan, the plan and our content priorities remain a solid foundation for our Society,” she emphasized. Digitization will enhance content and information availability, and Women in Pharma® and workforce development training programs will remain strong. The Society will continue to seek to expand its impact by increasing its global footprint, Barrick said, noting the recent addition of the Mexico and Eurasian Affiliates. She added that the ISPE Foundation is now poised for significant growth and will include the pursuit of initiatives targeted at increasing diversity in the pharmaceutical industry.
In addition, ISPE will continue to emphasize integration of conference, training, and guidance document offerings and place more emphasis on regulatory topic impact and activities, she said. Opportunities for more interface with the ISPE Board through conferences and participation in Chapter and Affiliate events can be expected.
ISPE delivers technical and operational solutions to support across the global pharmaceutical and biopharmaceutical industry in the manufacture of quality medicines for patients.
In each issue of Pharmaceutical Engineering®, we introduce a member of the ISPE staff who provides ISPE members with key information and services. Meet Matt Lehmann, Custom Training Manager, Professional Development.
This year, the ISPE Foundation made great strides in its mission of fueling global health equity by fostering access to knowledge and nurturing diverse talent.